Cargando…
Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
Prevention of preterm delivery is a major desiderate in contemporary obstetrics and a societal necessity. The means to achieve this goal remain elusive. Progesterone has been used in an attempt to prevent preterm delivery since the 1970s, but the evidence initially accumulated was fraught by mixed r...
Autores principales: | Vidaeff, Alex C, Belfort, Michael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714001/ https://www.ncbi.nlm.nih.gov/pubmed/23874089 http://dx.doi.org/10.2147/PPA.S35612 |
Ejemplares similares
-
Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
por: Sibai, Baha, et al.
Publicado: (2020) -
Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
por: Garcia, Stephanie M., et al.
Publicado: (2021) -
Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
por: Chollet, John L., et al.
Publicado: (2012) -
Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth
por: Travanty, Michael N, et al.
Publicado: (2018) -
Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth
por: Rouholamin, Safoura, et al.
Publicado: (2015)